Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Plasma Lipoprotein Response to a Single Subcutaneous Dose of Analogue Glucagon-like Peptide-2 in Humans

NCT03422666 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT03422666
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03422666 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Plasma Lipoprotein Response to a Single Subcutaneous Dose of Analogue Glucagon-like Peptide-2 in Humans
Lead sponsor
University Health Network, Toronto
Phase
Phase 2/3
Overall status
Completed
Start date
September 21, 2018
Completion date
December 1, 2021
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperlipidemias